MedTrace Logo

Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study

NCT05639569 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2025-06-22

No results posted yet for this study

Summary

The purpose of this study is to collect clinical data on patient outcomes, evaluate the safety and performance of Ankura TAA Stent Graft System and Surpass Super Stiff Guidewire, and build clinical evidence for patients with Descending Thoracic Aneurysm (DTA) or Type B Aortic Dissection (TBAD).

Conditions

  • Aneurysm Thoracic
  • Dissection of Thoracic Aorta

Interventions

DEVICE

Ankura™ TAA Stent Graft System

All patients will be implanted with Ankura™ TAA Stent Graft System in accordance with the instructions for use (IFU).

Sponsors & Collaborators

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-03
Primary Completion
2026-12-30
Completion
2030-12-30

Countries

  • Germany
  • Greece
  • Italy
  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05639569 on ClinicalTrials.gov